MAGE-3 peptide

• UNSPSC Description:

  MAGE-3 peptide (MAGE-3 168-176, human) is a peptide encoded by human MAGE-3 gene, which is expressed in tumor cells, presented by HLA and recognized by cytolytic T lymphocytes (CTL) as tumor antigen[1].

• Target Antigen:

  Others

• Type:

  Peptides

• Related Pathways:

  Others

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/mage-3-peptide.html

• Solubility:

  10 mM in DMSO

• Smiles:

  OC(CC[C@H](N)C(N[C@@H](C(C)C)C(N[C@@H](CC(O)=O)C(N1[C@@H](CCC1)C(N[C@@H]([C@@H](C)CC)C(NCC(N[C@H](C(N[C@@H](CC(C)C)C(N[C@H](C(O)=O)CC2=CC=C(C=C2)O)=O)=O)CC3=CN=CN3)=O)=O)=O)=O)=O)=O)=O

• Molecular Weight:

  1042.14

• References & Citations:

  [1]Schultz ES, et al., A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes. Tissue Antigens. 2001 Feb;57(2):103-9.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  154652-68-3